An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED

NCT07519902 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Persistent Corneal Epithelial Defect

Interventions

DRUG: Cenegermin
OTHER: Vehicle

Sponsor

Dompé Farmaceutici S.p.A